Inventor
GROVER GARY J
US17 patents
⚠️ This page may combine multiple inventors who share the name “GROVER GARY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SQUIBB & SONS INC
15 patentsUS4931464AJun 5, 1990
Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
SQUIBB & SONS INC60 citations95
US5643921AJul 1, 1997
Cardiopulmonary bypass and organ transplant using a potassium channel activator
SQUIBB & SONS INC26 citations92
US5140031AAug 18, 1992
Pyranyl cyanoguanidine derivatives
SQUIBB & SONS INC45 citations92
US5011837AApr 30, 1991
Aryl cyanoguanidines: potassium channel activators and method of making same
SQUIBB & SONS INC30 citations92
US4962095AOct 9, 1990
Method of reducing pre-and post-ischemic myocardial arrhythmias and fibrillation
SQUIBB & SONS INC33 citations92
US5008284AApr 16, 1991
Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
SQUIBB & SONS INC19 citations81
US5354764AOct 11, 1994
Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion
SQUIBB & SONS INC7 citations74
US5278169AJan 11, 1994
Method of treating or prevention of fibrillation of the heart
SQUIBB & SONS INC8 citations74
US5256688AOct 26, 1993
Method for inhibiting myocardial cell necrosis and preserving heart function during myocardial ischemia and/or reperfusion
SQUIBB & SONS INC12 citations74
US5116851AMay 26, 1992
Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides
SQUIBB & SONS INC8 citations73
US5066480ANov 19, 1991
Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist
SQUIBB & SONS INC16 citations72
US4931460AJun 5, 1990
Post-ischemic myocardial dysfunction using thromboxane A2 antagonists
SQUIBB & SONS INC9 citations66
US4857548AAug 15, 1989
Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A2 receptor antagonist
SQUIBB & SONS INC3 citations62
US4975279ADec 4, 1990
Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination
SQUIBB & SONS INC5 citations61
US4820733AApr 11, 1989
Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A2 receptor antagonist
SQUIBB & SONS INC0 citations52